Kidney transplantation in patients with a prior heart transplant

Transplantation

Volumn 89, Issue 4, 2010, Pages 427-433

  Cassuto, James R ^a   Reese, Peter ^a   Bloom, Roy D ^a   Doyle, Alden ^a   Goral, Simin ^a   Naji, Ali ^a   Abt, Peter L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chronic kidney disease; End stage renal disease; Heart transplantation; Renal transplantation

Indexed keywords

ADULT; ALLOGRAFT; ARTICLE; COHORT ANALYSIS; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL MORTALITY;

CADAVER; COHORT STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIVING DONORS; MIDDLE AGED; PATIENT SELECTION; POSTOPERATIVE PERIOD; REGISTRIES; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE DONORS; TREATMENT OUTCOME;

EID: 77649172635     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181c42248     Document Type: Article

References (23)

1. Barnard CN. Human cardiac transplantation. Am J Cardiol 1968; 22: 584.
2. Barnard CN. A human cardiac transplant: An interim report of a successful operation performed at Grote Schuur Hospital, Cape Town. South African Med J 1967; 41: 1271.
3. Vega JD, Moore J, Murray S, et al. Heart transplantation in the United States, 1998-2007. Am J Transplantation 2009; 9: 932.
4. Canales M, Youssef P, Spong R, et al. Predictors of chronic kidney disease in long-term survivors of lung and heart-lung transplantation. Am J Transplantation 2006; 6: 2157.
5. Mihatsch MJ, Antonovych T, Bohman SO, et al. Cyclosporin A ne-phropathy: Standardization of the evaluation of kidney biopsies. Clin Nephrol 1994; 41: 23.
6. Garrido IP, Crespo-Leiro MG, Paniagua MJ, et al. Independent predictors of renal dysfunction after heart transplantation in patients with normal pretransplant renal function. J Heart Lung Transplant 2005; 24: 1226.
7. Ojo AO, Help PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931.
8. Satchithananda DK, Parameshwar J, Sharples L, et al. The incidence of end-stage renal failure in 17 years of heart transplantation: A single center experience. J Heart Lung Transplant 2002; 21: 651.
9. Alam A, Badovinac K, Ivis F, et al. The outcome of heart transplant recipients following the development of end-stage renal disease: Anal-ysisof the Canadian Organ Replacement Register (CORR).AmJTrans-plantation 2007; 7: 461.
10. Ruble JR, Milford EL, McKay DB, et al. Renal insufficiency and end-stage renal disease in the heart transplant population. J Heart Lung Transplant 2004; 23: 289.
11. van Gelder T, Balk Ah, Zietse R, et al. Renal insufficiency after heart transplantation: A case-control study. Nephrol Dial Transplant 1998; 13: 2322.
12. Lee CK, Christensen LL, Magee JC, et al. Pre-transplant risk factors for chronic renal dysfunction after pediatric heart transplantation: A 10-year national cohort study. J Heart Lung Transplant 2007; 26: 458.
13. Villar E, Boissonnat P, Sebbag L, et al. Poor prognosis of heart transplant patients with end-stage renal failure. Nephrol Dial Transplant 2007; 22: 1383.
14. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725.
15. McCullough KP, Keith DS, Meyer KH, et al. Kidney and pancreas transplantation in the United States, 1998 -2007: Access for patients with diabetes and end-stage renal disease. Am J Transplantation 2009; 9: 894.
16. Mange K, Joffe MM, Feldman HI. Effect of the use or nonuse of long-term dialysison the subsequent survivalof renal transplants from living donors. N Engl J Med 2001; 8: 726.
17. Kasiske BL, Snyder JJ, Matas AJ, et al. Preemptive kidney transplantation: The advantage and the advantaged. J Am Soc Nephrol 2002; 13: 1358.
18. Meier-Kriesche H-U, Port F, OjoA, et al. Effect ofwaiting timeonrenal transplant outcome. Kidney Int 2000; 58: 1311.
19. Lonze BE, Warren DS, Stewart ZA, et al. Kidney transplantation in previous heart or lung recipients. Am J Transplant 2009; 9: 578.
20. Sung RS, Guidinger MK, Leichtman AB, et al. Impact of the expanded criteria donor allocation system on candidates for and recipients of expanded criteria donor kidneys. Transplantation 2007; 84: 1138.
21. Lin J, Valeri AM, Markowitz GS, et al. Angiotensin converting enzyme inhibition in chronic allograft nephropathy. Transplantation 2002; 73: 783.
22. Artz MA, Hilbrands LB, Borm G, et al. Blockade of the rennin-angiotensin system increases graft survival in patients with chronic allograft nephropathy. Nephrol Dial Transplant 2004; 19: 2852.
23. Kobashigawa JA, Miller LW, Russell SD, et al. Tacrolimus with mycophe-nolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1 year report. Am J Transplant 2006; 6: 1377.